SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • August 11th, 2023 • Alimera Sciences Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 11th, 2023 Company Industry JurisdictionTHIS SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of May 17, 2023 (the “Sixth Amendment Effective Date”), by and among SLR Investment Corp., a Maryland corporation (formerly known as Solar Capital LTD.) (“SLR”), as collateral agent (in such capacity, together with its successors and assigns in such capacity, “Collateral Agent”), the lenders party hereto including SLR in its capacity as a Lender (each a “Lender” and collectively, the “Lenders”), and Alimera Sciences, Inc., a Delaware corporation (“Borrower”).
OMNIBUS AMENDMENT TO EXIT FEE AGREEMENTSExit Fee Agreements • August 11th, 2023 • Alimera Sciences Inc • Pharmaceutical preparations
Contract Type FiledAugust 11th, 2023 Company IndustryTHIS OMNIBUS AMENDMENT TO EXIT FEE AGREEMENTS (this “Amendment”), dated as of May 18, 2023 (the “Sixth Amendment Effective Date”), is made by and among Alimera Sciences, Inc., a Delaware corporation (the “Borrower”), SLR Investment Corp. (formerly known as Solar Capital Ltd.) (“Solar”), in its capacity as collateral agent (together with its successors and assigns, in such capacity, “Collateral Agent”) and the Lenders listed on the signature pages hereto or otherwise a party to the Loan Agreement (as defined below) from time to time including Solar in its capacity as a Lender (each a “Lender” and collectively, the “Lenders”).
JOINDER AND AMENDMENT TO REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 11th, 2023 • Alimera Sciences Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 11th, 2023 Company Industry JurisdictionThis Joinder and Amendment to Registration Rights Agreement (this “Amendment”) dated as of May 17, 2023 (the “Amendment Effective Date”), between Alimera Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto, amends that certain Registration Rights Agreement (the “Registration Rights Agreement”) dated as of March 24, 2023, between the Company and the purchasers party thereto (the “Original Purchasers”).